AUB: Insurance Broker - Lloyd's Access Meets Digital Disruption
AUB: Insurance Broker - Lloyd's Access Meets Digital Disruption
In a Nutshell
Executive Summary
In a Nutshell
AUB Group is an insurance broker generating revenue through commissions on policy placements and advisory fees across Australia, New Zealand, and the UK. At A$24.47 versus fair value A$39.50, the stock offers 61% upside. The key driver is a strategic transformation through Lloyd's wholesale market access (via Tysers) and digital platform scaling (BizCover), trading at a 17% discount to peer valuations despite superior margins.
Investor Profiles
| Profile | Rating | Rationale |
|---|---|---|
| Income | ★★★☆☆ | Dividend yield 3.7% (91 cents FY25, 143 cents FY26e) with 49% payout ratio provides moderate income. Payout is sustainable given 55% free cash flow conversion and recurring revenue base. Growth trajectory is modest at 10-12% annually, limiting appeal for pure income seekers but adequate for balanced portfolios. |
| Value | ★★★★☆ | Trading at 9.2× EV/EBITDA versus peer median 11.1× (17% discount) despite 36% EBITDA margins (770 basis points above peers). The 61% upside to fair value provides substantial margin of safety. Near-term catalysts include FY26 results validation and Prestige integration milestones through 2026-27. |
| Growth | ★★☆☆☆ | Revenue growth moderating from 13% (FY25) to 6-8% (FY26-28) as hard insurance market cycle matures. Organic growth 8.4% currently but normalising to 5-6% reflects mid-cycle positioning. BizCover digital platform growing 15% provides growth optionality, but overall runway is constrained by market share (2% Australia) and cycle dynamics. |
| Quality | ★★★☆☆ | Strong business characteristics including 87% client retention and 80% recurring revenue, but ROIC of 8.2% trails WACC 9.6% (negative 1.4% spread). Management execution is proven (97% guidance achievement, Tysers integration success), though goodwill represents 55% of assets. The narrow moat (5-7 year duration) via Lloyd's access and partnership model supports quality, but capital efficiency requires improvement. |
| Thematic | ★★★★☆ | Plays insurance industry consolidation (17 transactions FY25, Prestige £219m acquisition) and SME insurance digitisation (BizCover 380k clients, 15% growth, 46% margins). Lloyd's specialty market access captures structural shift toward complex risk advisory. These themes have multi-year runway despite near-term cycle maturity concerns. |
Best Fit: Value Investors. The combination of material valuation discount (61% upside), peer-leading margins (36% EBITDA), and near-term re-rating catalysts creates textbook value opportunity. The 9.2× EV/EBITDA multiple fails to reflect strategic transformation through Lloyd's access and digital platforms. FY26 results and Prestige integration milestones provide measurable validation points over 12-18 months, making this suited for patient value investors seeking catalyst-driven re-ratings rather than speculation.
Executive Summary
AUB Group operates as an insurance broker across five divisions: Australian Broking (retail and commercial clients), International operations (Lloyd's wholesale via Tysers, UK retail via Prestige), Agencies (specialist insurance operations), New Zealand Broking, and BizCover (digital SME platform). Revenue comes from commissions on policy placements (10-25% of premiums) and advisory fees. The business model generates 80% recurring revenue through annual policy renewals.
FY25 delivered revenue of $1,501m (+13%) with EBITDA margins expanding to 36%, driven by the hard insurance market cycle (commercial renewal pricing 4% above historical norms) and elevated trust account interest income ($55m). Management completed 17 portfolio transactions including the £219m Prestige acquisition, the largest in company history.
The investment case rests on three pillars: sustainable competitive advantages through Lloyd's wholesale access (5-7 year moat duration) and a partnership model generating superior retention (87% versus peer 82%), demonstrated management execution (97% historical guidance achievement), and multiple growth drivers including UK retail scaling via Prestige (targeting $10m synergies by FY27) and BizCover expansion toward 50% margins. Key risks include hard market cycle reversal (35% probability FY27-28) and interest rate normalisation compressing trust income by $15-20m.
At A$24.47 versus fair value A$39.50, the stock is 61% undervalued.
Results & Outlook
What happened?
FY25 revenue grew 13% to $1,501m driven by hard market pricing (commercial premiums up 5-7%), Tysers integration, and organic growth of 8.4%. EBITDA margins expanded 70 basis points to 36%, though this includes cyclically elevated trust account interest income of $55m (versus $28-38m normalised). The partnership business model sustained client retention at 87%, improving toward a 91% target. Management completed 17 transactions including five acquisitions, with the January 2026 Prestige purchase (£219m) adding £320m of UK retail GWP. Free cash flow reached $452m despite acquisition activity.
| Metric | FY25A | FY26E | FY27E |
|---|---|---|---|
| Revenue ($m) | 1,501 | 1,666 | 1,764 |
| EBITDA ($m) | 534 | 590 | 621 |
| EBITDA Margin (%) | 35.6 | 35.4 | 35.2 |
| EPS ($) | 2.84 | 2.91 | 3.09 |
| Client Retention (%) | 87 | 88 | 89 |
| BizCover Clients ('000) | 380 | 437 | 502 |
What's next?
FY26 guidance of $215-227m underlying NPAT was reaffirmed in January 2026, with first-half results tracking at $90-91m. Revenue growth moderates to 11% (FY26) then 6% (FY27) as the hard market cycle matures and organic growth normalises to 5-6%. Margins compress gradually from the current 36% peak toward 31% terminal levels as competitive intensity increases and trust income normalises. Key catalysts include Prestige integration milestones (client retention data, synergy realisation pace toward $10m target by end FY27), BizCover platform scaling (targeting 50% EBITDA margins with embedded insurance partnerships), and bolt-on M&A execution. The insurance cycle trajectory through FY27-28 represents the critical variable, with Lloyd's capacity expansion (+12%) signalling potential pricing reversion from current elevated levels.
Valuation & Risks
| Metric | Value |
|---|---|
| Fair Value | A$39.50 |
| Current Price | A$24.47 |
| Upside | +61% |
| EV/EBITDA (Current) | 9.2× |
| EV/EBITDA (Peer Median) | 11.1× |
What could go wrong?
The hard insurance market cycle represents the most material risk to the thesis, carrying 35% probability of reversal in FY27-28. Commercial renewal pricing currently runs 4% above historical norms, driven by Lloyd's capacity constraints and catastrophic loss experience. Leading indicators suggest this is Year 4 of a typical 5-7 year cycle, with Lloyd's capacity now expanding 12%. A cycle turn would eliminate 60% of recent organic growth as premium rates moderate from current +5-7% to historical +2% or potentially negative territory. Revenue impact: -$45-60m in Year 3 of a downturn. This combines with interest rate normalisation risk—trust account cash of $1.06bn currently generates $55m income at 4.35% rates, but RBA rate cuts of 100-150 basis points over 18 months would reduce this by $15-20m, flowing directly to EBITDA. The correlated nature of these risks (both driven by economic normalisation) creates a bear case scenario with -18% revenue decline versus base case by Year 3, compressing margins to 28% and fair value to $30.41 per share.